The Medicines Company to Present at the 36th Annual J. P. Morgan Healthcare Conference

3 Jan 2018

PARSIPPANY, N.J.--(BUSINESS WIRE)--Jan. 3, 2018-- The Medicines Company (NASDAQ:MDCO) today announced that its Chief Executive Officer, Clive Meanwell, M.D., Ph.D., will present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018, at 8:30 a.m., Pacific Time, at The Westin St. Francis in San Francisco, CA. A Q&A breakout session will immediately follow the presentation at 9:00 a.m., Pacific Time.

A live audio webcast of the presentation and the breakout session will be available in the “Investors” section of The Medicines Company website,, under “Events/Presentations.” A replay of the presentation and breakout session will be available for a limited time following the event.

About The Medicines Company

The Medicines Company is a biopharmaceutical company driven by an overriding purpose – to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in cardiovascular care. The Company is headquartered in Parsippany, New Jersey, with a global innovation center in California.

Source: The Medicines Company

The Medicines Company
Meg Langan, 973-290-6319
Vice President
Investor Relations
Krishna Gorti, M.D., 973-290-6122
Vice President, Investor Relations